The activation of the PI3K-AKT and ERK-1/2 pathways, both associated with EMT in prostate cancer [52, 53], supported the conclusion that miR-652 induces EMT in PC3 prostate cancer cells (Figure 8A). This evidence concerns the gene MAPK3 and prostate carcinoma.